The global cardiac bio-implant devices market is witnessing growth due to high incidences of cardiovascular diseases and increasing geriatric population. The massive unexplored cardiac bio-implant devices market in the emerging economies is creating ample opportunities for the growth of the global cardiac bio-implant devices market, at a considerable rate in the coming years. The advanced research and development activities and new product developments by the major players are supporting the demand for cost effective and efficient cardiac bio-implant devices, thus fuelling the growth of the global cardiac bio-implant devices market.
Cardiovascular disease refers to the disease of heart or blood vessels, which are mainly caused due to blood clot or cholesterol deposit inside an artery. Cardiovascular diseases are of several types including coronary heart disease, rheumatic heart disease, peripheral arterial disease, congenital heart disease, deep vein thrombosis, and pulmonary embolism. Some of the major risk-leading habits towards cardiovascular diseases are high blood pressure, high blood cholesterol, diabetes, smoking and obesity. Moreover, alcohol, lack of exercise and poor nutrition may also cause heart diseases. According to the WHO, cardiovascular diseases are the major cause of all deaths worldwide. The organization also reported that 17.5 million people died from cardiovascular diseases in 2012, representing 31% of all deaths globally.
Cardiac bio-implant devices are the medical devices used for the treatment of cardiovascular diseases. Cardiac bio-implants have unique compatibility with body tissues or blood. The different implantable cardiovascular devices available are pacemakers, heart valves, cardioverter defibrillators and stents.
The global cardiac bio-implant devices market is segmented into pacing devices, stents and related implants, and structural cardiac implants. The pacing devices segment comprises implantable cardiac pacemakers (ICPs), implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs) and pacing accessories. The stents and related implants segment includes coronary stents, peripheral stents and stent-related implants; whereas, the structural cardiac implants segment comprises heart valves and accessories, insertable loop recorders/implantable heart monitors, and ventricular-assist devices.
Some of the factors driving the growth of the global cardiac bio-implant devices market are increasing healthcare expenditure, aging population and growing incidences of cardiovascular diseases. In addition, the technological advancements and high investments for the development and manufacturing of cardiac bio-implant devices are fueling the growth of the global cardiac bio-implant devices. However, high cost of cardiac bio-implant devices, complications associated with the usage of these devices and stringent regulatory requirements for the approval of cardiac bio-implant devices are some of the factors, restraining the growth of the global cardiac bio-implant devices market to some extent.
Geographically, North America leads the global cardiac bio-implant devices market due to high healthcare expenditure, aging population and high prevalence of cardiovascular diseases. In addition, the technological advancement and high investment by major players for the development of cardiac bio-implant devices are fueling the growth of the cardiac bio-implant devices market in North America. Asia-Pacific is the fastest growing region in the global cardiac bio-implant devices market, driven by improving healthcare infrastructure, growing healthcare expenditure and high prevalence of cardiovascular diseases. Moreover, the Asia-Pacific cardiac bio-implant devices market is growing rapidly due increasing research and development activities and increasing awareness about cardiac bio-implant devices among patients and healthcare providers in emerging economies, such as India and China.
The key players operating in the global cardiac bio-implant devices market are St. Jude Medical Inc., Medtronic, Boston Scientific Corporation, Johnson & Johnson Services Inc., Sorin Group, Abbott and Edwards Lifesciences Corporation.
Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
Uncovers potential demands in the market
Porter analysis identifies competitive forces within the market
Provides information on the historical and current market size and the future potential of the market
Provides sizes of key regional markets using yardsticks of segments
Highlights the competitive scenario of the market and major competitors
Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics. Profiles provide better understanding of competition as well as the demands of the market.